DNB FUND - Health Care Retail A (EUR)

Reference Data

ISIN LU1660425346
Valor Number 37774288
Bloomberg Global ID
Fund Name DNB FUND - Health Care Retail A (EUR)
Fund Provider DNB Asset Management AS Stockholm, Sweden
Phone: +46 8 473 41 00
Web: www.cim.se
Fund Provider DNB Asset Management AS
Representative in Switzerland FundPartner Solutions (Suisse) SA
Genève 75
Distributor(s) Allfunds International Schweiz AG DZ Private Bank (schweiz) AG Fund Channel (Suisse) SA
Nyon 2
Phone: +4122 0000 Swissquote Bank
Gland
Phone: +41 22 999 94 11 UBS AG
Zürich
Phone: +41 44 234 11 11
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** Emphasis is placed on investments in the equities of companies operating in or associated with the health care sectors. Geographically the Sub-Fund has full flexibility. The Sub-Fund may invest between 5% and 15% of its net assets in equities quoted on the Hong Kong Stock exchange or on the Shanghai Stock exchange.
Peculiarities

Fund Prices

Current Price * 16.84 EUR 20.12.2024
Previous Price * 16.91 EUR 19.12.2024
52 Week High * 18.37 EUR 30.08.2024
52 Week Low * 16.05 EUR 22.12.2023
NAV * 16.84 EUR 20.12.2024
Issue Price * 16.84 EUR 20.12.2024
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 63,132,030
Unit/Share Assets *** 7,271,253
Trading Information SIX

Performance

YTD Performance +4.18% 29.12.2023
20.12.2024
YTD Performance (in CHF) +4.55% 29.12.2023
20.12.2024
1 month -1.69% 20.11.2024
20.12.2024
3 months -4.45% 20.09.2024
20.12.2024
6 months -4.36% 20.06.2024
20.12.2024
1 year +6.43% 20.12.2023
20.12.2024
2 years +4.06% 20.12.2022
20.12.2024
3 years +8.18% 20.12.2021
20.12.2024
5 years +27.01% 30.04.2020
20.12.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Novo Nordisk AS Class B 7.35%
Johnson & Johnson 6.36%
Eli Lilly and Co 6.24%
AstraZeneca PLC 6.20%
Roche Holding AG 5.82%
Lonza Group Ltd 4.29%
Thermo Fisher Scientific Inc 3.92%
UnitedHealth Group Inc 3.67%
AbbVie Inc 3.14%
Pfizer Inc 2.93%
Last data update 31.10.2024

Cost / Risk

TER *** 1.64%
TER date *** 30.06.2024
Performance Fee *** 20.00%
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.60%
SRRI ***
SRRI date *** 30.11.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)